title: Reply to Letter: "Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer".
authors.affiliation: Department of Surgery Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka City, Japan.
authors.forename: Hidenori
authors.initials: H
authors.lastname: Takahashi
authors.forename: Osamu
authors.initials: O
authors.lastname: Ishikawa
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D059248:Chemoradiotherapy; D003841:Deoxycytidine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000628:therapy*; D011300:Preoperative Care
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine